DK1751131T3 - MTP-inhiberende arylpiperidiner eller -piperaziner, der er substitueret med 5-leddede heterocykler - Google Patents
MTP-inhiberende arylpiperidiner eller -piperaziner, der er substitueret med 5-leddede heterocyklerInfo
- Publication number
- DK1751131T3 DK1751131T3 DK05716940T DK05716940T DK1751131T3 DK 1751131 T3 DK1751131 T3 DK 1751131T3 DK 05716940 T DK05716940 T DK 05716940T DK 05716940 T DK05716940 T DK 05716940T DK 1751131 T3 DK1751131 T3 DK 1751131T3
- Authority
- DK
- Denmark
- Prior art keywords
- arylpiperidines
- mtp
- inhibiting
- membered heterocycles
- piperazines substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04075771 | 2004-03-10 | ||
US55633604P | 2004-03-25 | 2004-03-25 | |
PCT/EP2005/051010 WO2005085226A1 (en) | 2004-03-10 | 2005-03-07 | Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1751131T3 true DK1751131T3 (da) | 2009-03-16 |
Family
ID=34928108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05716940T DK1751131T3 (da) | 2004-03-10 | 2005-03-07 | MTP-inhiberende arylpiperidiner eller -piperaziner, der er substitueret med 5-leddede heterocykler |
Country Status (27)
Country | Link |
---|---|
US (2) | US7504400B2 (pt) |
EP (1) | EP1751131B1 (pt) |
JP (1) | JP4846709B2 (pt) |
KR (1) | KR101171211B1 (pt) |
CN (1) | CN1930143B (pt) |
AR (1) | AR048316A1 (pt) |
AT (1) | ATE414698T1 (pt) |
AU (1) | AU2005219580B2 (pt) |
BR (1) | BRPI0508514A (pt) |
CA (1) | CA2558506C (pt) |
DK (1) | DK1751131T3 (pt) |
EA (1) | EA009455B1 (pt) |
ES (1) | ES2317206T3 (pt) |
HK (1) | HK1103582A1 (pt) |
IL (1) | IL177939A (pt) |
JO (1) | JO2537B1 (pt) |
MX (1) | MXPA06010253A (pt) |
MY (1) | MY142521A (pt) |
NZ (1) | NZ548817A (pt) |
PA (1) | PA8625401A1 (pt) |
PL (1) | PL1751131T3 (pt) |
PT (1) | PT1751131E (pt) |
SI (1) | SI1751131T1 (pt) |
TW (1) | TWI353984B (pt) |
UA (1) | UA85215C2 (pt) |
WO (1) | WO2005085226A1 (pt) |
ZA (1) | ZA200607542B (pt) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009509988A (ja) | 2005-09-29 | 2009-03-12 | サノフィ−アベンティス | フェニル−及びピリジニル−1,2,4−オキサジアゾロン誘導体、その製造方法、及び医薬品としてのその使用 |
WO2007053436A1 (en) * | 2005-10-31 | 2007-05-10 | Janssen Pharmaceutica N.V. | Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
AU2007283113A1 (en) | 2006-08-08 | 2008-02-14 | Sanofi-Aventis | Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use |
US8404896B2 (en) | 2006-12-01 | 2013-03-26 | Bristol-Myers Squibb Company | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
DE102007005045B4 (de) | 2007-01-26 | 2008-12-18 | Sanofi-Aventis | Phenothiazin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE102007054497B3 (de) | 2007-11-13 | 2009-07-23 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung |
US20120015957A1 (en) * | 2007-12-17 | 2012-01-19 | Wenying Chai | Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
US20090197947A1 (en) * | 2008-02-01 | 2009-08-06 | The Research Foundation Of State University Of New York | Medicaments and methods for lowering plasma lipid levels and screening drugs |
CA2713322C (en) | 2008-02-06 | 2017-01-17 | Astrazeneca Ab | Diazaspiro [5.5] undecane derivatives and their use in the treatment of pulmonary disorders |
UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
GB0913342D0 (en) | 2009-07-31 | 2009-09-16 | Astrazeneca Ab | Compounds - 801 |
KR20120060207A (ko) | 2009-08-26 | 2012-06-11 | 사노피 | 신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도 |
CA2798002C (en) * | 2010-05-19 | 2019-12-03 | Sandoz Ag | Process for the preparation of chiral triazolones |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
EP2683703B1 (de) | 2011-03-08 | 2015-05-27 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120058A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120050A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8710050B2 (en) | 2011-03-08 | 2014-04-29 | Sanofi | Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120051A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2683700B1 (de) | 2011-03-08 | 2015-02-18 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013175215A1 (en) | 2012-05-22 | 2013-11-28 | Autifony Therapeutics Limited | Triazoles as kv3 inhibitors |
CA2905751A1 (en) | 2013-03-13 | 2014-10-09 | Forma Therapeutics, Inc. | Novel compounds and compositions for inhibition of fasn |
KR101720937B1 (ko) * | 2013-04-25 | 2017-03-29 | 주식회사유한양행 | 신규의 트라이아졸론 유도체 또는 그의 염 및 이를 포함하는 약학 조성물 |
WO2014202505A1 (de) | 2013-06-20 | 2014-12-24 | Bayer Cropscience Ag | Arylsulfid- und arylsulfoxid-derivate als akarizide und insektizide |
US9981940B2 (en) | 2013-06-20 | 2018-05-29 | Bayer Cropscience Aktiengesellschaft | Aryl sulfide derivatives and aryl sulfoxide derivatives as acaricides and insecticides |
EP3028703B1 (en) | 2013-07-29 | 2019-12-04 | Kyowa Kirin Co., Ltd. | Piperidine derivatives as wnt signaling inhibitor |
WO2015200674A1 (en) * | 2014-06-25 | 2015-12-30 | The General Hospital Corporation | Neuroactive compounds and methods of using the same |
GB201601301D0 (en) * | 2016-01-25 | 2016-03-09 | Takeda Pharmaceutical | Novel compounds |
ES2781309T3 (es) * | 2016-05-27 | 2020-09-01 | Bristol Myers Squibb Co | Triazolonas y tetrazolonas como inhibidores de ROCK |
MX2019000512A (es) | 2016-07-12 | 2019-05-02 | Bayer Cropscience Ag | Compuestos biciclicos como plaguicidas. |
JP7190906B2 (ja) | 2017-01-24 | 2022-12-16 | 住友化学株式会社 | 縮合複素環化合物及びそれを含有する組成物 |
TWI767148B (zh) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | 抑制脂肪酸合成酶(fasn) |
US10793554B2 (en) | 2018-10-29 | 2020-10-06 | Forma Therapeutics, Inc. | Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone |
WO2022187206A1 (en) * | 2021-03-01 | 2022-09-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Dual-target mu opioid and dopamine d3 receptors ligands; preparation and use thereof |
GB202216960D0 (en) * | 2022-11-14 | 2022-12-28 | Addex Pharmaceuticals Sa | Novel compounds |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9826412D0 (en) | 1998-12-03 | 1999-01-27 | Glaxo Group Ltd | Chemical compounds |
GB0013383D0 (en) | 2000-06-01 | 2000-07-26 | Glaxo Group Ltd | Therapeutic benzamide derivatives |
GB0013346D0 (en) * | 2000-06-01 | 2000-07-26 | Glaxo Group Ltd | Therapeutic benzamide derivatives |
JO2654B1 (en) * | 2000-09-04 | 2012-06-17 | شركة جانسين فارماسوتيكا ان. في | Multiple aryl caroxa amides are useful as lipid - lowering agents |
-
2005
- 2005-03-07 PT PT05716940T patent/PT1751131E/pt unknown
- 2005-03-07 NZ NZ548817A patent/NZ548817A/en not_active IP Right Cessation
- 2005-03-07 PL PL05716940T patent/PL1751131T3/pl unknown
- 2005-03-07 ES ES05716940T patent/ES2317206T3/es active Active
- 2005-03-07 AU AU2005219580A patent/AU2005219580B2/en not_active Ceased
- 2005-03-07 WO PCT/EP2005/051010 patent/WO2005085226A1/en active Application Filing
- 2005-03-07 EA EA200601660A patent/EA009455B1/ru not_active IP Right Cessation
- 2005-03-07 BR BRPI0508514-4A patent/BRPI0508514A/pt not_active Application Discontinuation
- 2005-03-07 US US10/589,515 patent/US7504400B2/en active Active
- 2005-03-07 EP EP05716940A patent/EP1751131B1/en active Active
- 2005-03-07 CN CN2005800074663A patent/CN1930143B/zh not_active Expired - Fee Related
- 2005-03-07 DK DK05716940T patent/DK1751131T3/da active
- 2005-03-07 KR KR1020067016095A patent/KR101171211B1/ko not_active IP Right Cessation
- 2005-03-07 CA CA2558506A patent/CA2558506C/en not_active Expired - Fee Related
- 2005-03-07 JP JP2007502335A patent/JP4846709B2/ja not_active Expired - Fee Related
- 2005-03-07 JO JO200526A patent/JO2537B1/en active
- 2005-03-07 MX MXPA06010253A patent/MXPA06010253A/es active IP Right Grant
- 2005-03-07 AT AT05716940T patent/ATE414698T1/de active
- 2005-03-07 SI SI200530555T patent/SI1751131T1/sl unknown
- 2005-03-08 PA PA20058625401A patent/PA8625401A1/es unknown
- 2005-03-09 MY MYPI20050983A patent/MY142521A/en unknown
- 2005-03-09 AR ARP050100904A patent/AR048316A1/es not_active Application Discontinuation
- 2005-03-09 TW TW094107062A patent/TWI353984B/zh not_active IP Right Cessation
- 2005-07-03 UA UAA200608684A patent/UA85215C2/uk unknown
-
2006
- 2006-09-07 IL IL177939A patent/IL177939A/en not_active IP Right Cessation
- 2006-09-08 ZA ZA200607542A patent/ZA200607542B/en unknown
-
2007
- 2007-07-23 HK HK07107947.2A patent/HK1103582A1/xx not_active IP Right Cessation
-
2008
- 2008-12-22 US US12/341,567 patent/US7816360B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1751131T3 (da) | MTP-inhiberende arylpiperidiner eller -piperaziner, der er substitueret med 5-leddede heterocykler | |
LTPA2016037I1 (lt) | Nauji heterocikliniai junginiai, veiksmingi kaip beta-laktamazės slopikliai | |
ATE437875T1 (de) | Heterozyklische antivirale verbindungen | |
DK1919907T3 (da) | Heterocyklisk forbindelse | |
DK1740591T3 (da) | Heterobicykliske proteinkinaseinhibitorer substitueret med en 6,6-biocyclisk ring | |
ATE494287T1 (de) | Pyrazolopyrimidinderivate als inhibitoren der cyclinabhängigen kinase | |
ATE477257T1 (de) | Piperidinylamino-thienoä2,3-dü- pyrimidinverbindungen | |
DE602006015607D1 (de) | Thiazol-4-carboxamid-derivate als mglur5-antagonisten | |
DK1937650T3 (da) | Heterocykliske forbindelser | |
IS8578A (is) | 3- karbamoýl - 2- pýridón afleiður | |
ATE461191T1 (de) | N-substituierte 2-oxodihydropyridinderivate als npy antagonisten | |
IS8348A (is) | Samrunnin heteróhringasambönd | |
DK1824856T3 (da) | 2,4 (4,6)-pyrimidinderivater | |
ATE520671T1 (de) | Pyrimidin-harnstoff-derivate als kinase-hemmer | |
ATE394399T1 (de) | Tetrahydropyridoindolderivate | |
ATE383361T1 (de) | Pyrrazolopyrimidinderivate | |
ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
NO20054854D0 (no) | Femrings heterocykliske derivater | |
NL1030382A1 (nl) | Gesubstitueerde N-sulfonylaminobenzyl-2-fenoxyaceetamide verbindingen. | |
DK1711177T3 (da) | 1H-thieno-2,3-c-pyrazolderivater, der er egnede som kinase-I-inhibitorer | |
DK1954668T3 (da) | Homo- og heterocykliske forbindelser, der er egnede som CETP-inhibitorer | |
DE602004019555D1 (de) | Heterocyclische 7-aminoalkylidenylchinolone und -naphthyridone | |
IL183647A (en) | The heterocyclic compounds are converted into 3-ethylidenehydrazino | |
NO20070299L (no) | Novel heterocyclic compounds | |
BRPI0509256A (pt) | derivados de pirrolidina-3,4-dicarboxamida |